How Big is the Prostate Cancer Therapy Market | Manufacturers and Suppliers 2025

Code: MTA8376 Publication Date: Aug 2025

What is the size of Prostate Cancer Therapy Market?

According to 6Wresearch internal database and industry insights, the Prostate Cancer Therapy Market was estimated at USD 13 billion in 2024 and is projected to reach USD 24 billion by 2031, expanding at a compound annual growth rate of 8.2% during the forecast period 2024–2031.

Prostate Cancer Therapy Market is expected to rise in the forthcoming years due to numbers of factors include the increasing incidence of prostate cancer, rising adoption of advanced treatment modalities, ongoing research in targeted therapies, and government support for oncology healthcare.

Key Growth Drivers of the Prostate Cancer Therapy Market

  • Rising prevalence of prostate cancer worldwide
  • Growing adoption of targeted therapies, immunotherapy, and hormone therapy
  • Advancements in minimally invasive surgical techniques and radiotherapy
  • Increasing government and private funding for oncology treatments
  • Growing awareness for early-stage therapy and personalized treatment approaches

Prostate Cancer Therapy Market Trends

Prostate Cancer Therapy Market is expanding its landscape with strong trends including the adoption of advanced hormonal and targeted therapies for metastatic and high-risk patients. Other trends, such as minimally invasive surgeries and combination therapies, are improving patient outcomes. Further, this market is integrated with AI and digital health in treatment planning which is enhancing therapy precision and monitoring.

Emerging Developments in the Prostate Cancer Therapy Market

Prostate Cancer Therapy Market is evolving throughout the years with continuous innovations in immunotherapy, radioligand therapy, and precision medicine. On the other hand, collaborations are growing between pharmaceutical companies and research institutes are increasing to accelerate drug development. Further, clinical trials for novel therapies and investments in personalized treatment platforms are boosting market growth.

List of Leading Companies in the Prostate Cancer Therapy Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Astellas Pharma Inc.

Company NameAstellas Pharma Inc.
Established Year2005
HeadquartersTokyo, Japan
Official WebsiteClick Here

This company develops hormonal therapies and targeted drugs for prostate cancer and focuses on improving survival and quality of life for patients.

2. Pfizer Inc.

Company NamePfizer Inc.
Established Year1849
HeadquartersNew York, USA
Official WebsiteClick Here

This company provides advanced hormonal, targeted, and chemotherapy drugs for prostate cancer and emphasizes research-driven oncology solutions.

3. Novartis AG

Company NameNovartis AG
Established Year1996
HeadquartersBasel, Switzerland
Official WebsiteClick Here

This company offers innovative therapies including radioligand therapy and targeted drugs and focuses on improving treatment efficacy and patient outcomes.

4. Janssen Pharmaceuticals

Company NameJanssen Pharmaceuticals
Established Year1886
HeadquartersNew Jersey, USA
Official WebsiteClick Here

This company develops immunotherapies and hormone-based therapies for prostate cancer and prioritizes patient-centric and precision treatment approaches.

5. Bayer AG

Company NameBayer AG
Established Year1863
HeadquartersLeverkusen, Germany
Official WebsiteClick Here

This company provides targeted therapies and combination treatment solutions for prostate cancer and emphasizes oncology innovation and clinical research.

6. Sanofi S.A.

Company NameSanofi S.A.
Established Year1973
HeadquartersParis, France
Official WebsiteClick Here

This company develops hormone therapies and advanced treatment options for prostate cancer and focuses on personalized patient care and research.

7. AstraZeneca plc

Company NameAstraZeneca plc
Established Year1999
HeadquartersCambridge, UK
Official WebsiteClick Here

This company offers targeted therapies, immunotherapies, and combination treatments for prostate cancer and focuses on innovation and global patient access.

8. Takeda Pharmaceutical Company Limited

Company NameTakeda Pharmaceutical Company Limited
Established Year1781
HeadquartersOsaka, Japan
Official WebsiteClick Here

This company provides hormonal therapies and clinical-stage oncology drugs and emphasizes precision medicine and patient-focused solutions.

9. Eli Lilly and Company

Company NameEli Lilly and Company
Established Year1876
HeadquartersIndiana, USA
Official WebsiteClick Here

This company develops androgen receptor inhibitors and targeted therapies and focuses on improving therapeutic outcomes and advancing cancer care.

10. GlaxoSmithKline plc

Company NameGlaxoSmithKline plc
Established Year2000
HeadquartersBrentford, UK
Official WebsiteClick Here

This company provides immunotherapies and precision oncology solutions and emphasizes research-driven treatment and patient support programs.

How Big is the Prostate Cancer Therapy Market : FAQs

The Prostate Cancer Therapy market was valued at USD 13 billion in 2023 and is projected to reach USD 24 billion by 2031.
Growth factors include rising incidence, adoption of advanced therapies, ongoing research, and government support for oncology care.
Hospitals, oncology centres, specialty clinics, and research institutes are key adopters.
Major companies include Astellas Pharma, Pfizer, Novartis, Johnson & Johnson, Bayer, Sanofi, AstraZeneca, Takeda, Eli Lilly, and GSK.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All